Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Yamada

Showing results (281-290 of 300) with videos related to

Pageof 30
Sort By:
Annals of Surgical Oncology|July 9, 2017
Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is the Best Candidate?Tohru Nakagawa, Satoru Taguchi, Atsushi Kanatani, et al.
The Journal of Dermatology|December 10, 2025
Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Cutaneous Squamous Cell Carcinoma 2025Toshihiro Takai, Takafumi Kadono, Noriki Fujimoto, et al.
Japanese Journal of Clinical Oncology|June 27, 2025
Predictive ability of the geriatric 8 screening tool for treatment completion of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy in patients with urothelial carcinomaYoshiaki Kurokawa, Taketo Kawai, Satoru Taguchi, et al.
World Journal of Urology|February 4, 2023
Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective studyYukio Yamada, Tohru Nakagawa, Jimpei Miyakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 23, 2023
Enfortumab vedotin versus platinum rechallenge in post-platinum, post-pembrolizumab advanced urothelial carcinoma: A multicenter propensity score-matched studySatoru Taguchi, Taketo Kawai, Yoshiki Ambe, et al.
Urologic Oncology|January 24, 2017
Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladderTohru Nakagawa, Satoru Taguchi, Yukari Uemura, et al.
Life Science Alliance|April 3, 2019
Human NK cell development in hIL-7 and hIL-15 knockin NOD/SCID/IL2rgKO miceMasashi Matsuda, Rintaro Ono, Tomonori Iyoda, et al.
Cell Reports|March 22, 2018
Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture SystemRaul Vizcardo, Nicholas D Klemen, S M Rafiqul Islam, et al.
Immunotherapy|May 16, 2023
Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumabSatoru Taguchi, Taketo Kawai, Sebastiano Buti, et al.
Eneuro|April 5, 2017
Transgenic Monkey Model of the Polyglutamine Diseases Recapitulating Progressive Neurological SymptomsIkuo Tomioka, Hidetoshi Ishibashi, Eiko N Minakawa, et al.
Pageof 30

Showing results (281-290 of 300) with videos related to

Sort By:
Pageof 30
Annals of Surgical Oncology|July 9, 2017
Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is the Best Candidate?Tohru Nakagawa, Satoru Taguchi, Atsushi Kanatani, et al.
The Journal of Dermatology|December 10, 2025
Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Cutaneous Squamous Cell Carcinoma 2025Toshihiro Takai, Takafumi Kadono, Noriki Fujimoto, et al.
Japanese Journal of Clinical Oncology|June 27, 2025
Predictive ability of the geriatric 8 screening tool for treatment completion of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy in patients with urothelial carcinomaYoshiaki Kurokawa, Taketo Kawai, Satoru Taguchi, et al.
World Journal of Urology|February 4, 2023
Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective studyYukio Yamada, Tohru Nakagawa, Jimpei Miyakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 23, 2023
Enfortumab vedotin versus platinum rechallenge in post-platinum, post-pembrolizumab advanced urothelial carcinoma: A multicenter propensity score-matched studySatoru Taguchi, Taketo Kawai, Yoshiki Ambe, et al.
Urologic Oncology|January 24, 2017
Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladderTohru Nakagawa, Satoru Taguchi, Yukari Uemura, et al.
Life Science Alliance|April 3, 2019
Human NK cell development in hIL-7 and hIL-15 knockin NOD/SCID/IL2rgKO miceMasashi Matsuda, Rintaro Ono, Tomonori Iyoda, et al.
Cell Reports|March 22, 2018
Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture SystemRaul Vizcardo, Nicholas D Klemen, S M Rafiqul Islam, et al.
Immunotherapy|May 16, 2023
Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumabSatoru Taguchi, Taketo Kawai, Sebastiano Buti, et al.
Eneuro|April 5, 2017
Transgenic Monkey Model of the Polyglutamine Diseases Recapitulating Progressive Neurological SymptomsIkuo Tomioka, Hidetoshi Ishibashi, Eiko N Minakawa, et al.
Pageof 30